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In the text that follows, the development of a coherent and recogniz-
able teaching and research field devoted to the development of the 
behavioral and social sciences in pharmacy is proposed. It is impor-
tant for teachers and researchers in this field to establish a common 
and recognizable identity; to share basic definitions, purposes and 
criteria; and to develop forums (such as scientific meetings ·and 
perhaps a journal) for the exchange and nourishment of the behavioral 
science knowledge that they generate. It is suggested that this field be 
called behavioral pharmacy. This title is suggested primarily because 
Of recent· pirticipant agreement and NIH legitimization given to the 
title "behavioral medicine" for a closely allied field concerned with 
behavior and health(l). . 
The 1976 rePOrt of the Study Commission on Pharmacy, better 
kliowt1 as the Millis Commission Report, called attention to the need 
for developirig the behavioral· and social sciences in pharmacy(2): 
.. · . ~ ''i'he ·StUdy coiDitlission emphasizes that pharmacy is a 
knowledge system in which chemical substances and people 
called patients interact. Needed and optimally effective drug 
therapy results only when the drugs and those, who consume 
them are fully understood, We suggest that one of the fll'St steps 
in reviewing the educational program of a college of phannacy 
should be weighing the relative emphasis given to the physical 
and' biological sciences against the behavioral and social, sci-
ences in the curriculum for the first professional degree." 
The recommendations of this report reflect rapidly growing concern 
within pharmacy, as within the other health professions, about the 
need to apply behavioral science knowledge to health care. 
Behavioral pharmacy is distinct from, although it overlaps with, 
behavioral medicine, psychosomatic medicine, psychophannacolo8>:, 
medical sociology, medical anthropology, health psychology, medi· 
cal economics, and educational research in pharmacy. The following 
definition is proposed: 
"Behavioral pharmacy is the field concerned with the t:!evel- . 
opment of behavioral science knowledge and techniques re~. 
vant to the understanding ·or drug use, drug eff~. drug selec~ 
tion and prescribing, behavioral-therapy adjunct~! @llCi al~­
tives to drug therapies, .the professional beJaavio.r.~. !lcll~ 
being of pharmacy practitioners, and the applit:tlliOn ,Q(tms 
knowledge and these techniques to prevention, diagnosi$, 
treatment and rehabilitation." 
Having proposed this veiy general definition of bebavi~:~ 
macy, what is taught will now be specified, followed by a ~l()Jl 
of the scientific nature of Wbat.is taught. ,. · · .,:·:· 
: i' ~. < "J. ' 
TEACHING BEHAVIORAL PHARMACY 
.:r.--: 
. • .tnmqliilizels~'-and 4iltematives:to drugs for §beSs · 
. ::.oor~~;:; ... , ;cc:;?:;•;d;?t >~:i.;t3Hc:•,•• (~;X:;L' ·t"in 
(~ii) MaximiZiDg intended drug effects aDd minimizing unin-
,.(.!;'.'_ 
(.tv) The ~ts role m ·. g . . •••<. ,, , .. ;.c: 
~=!]f!:¥:~~0~"~.~ 
(ii) The impactOf dt~ ~th prt:Jfession on ~~th be~vior. 
(iii) 'lbe s~y of'atternativehealth~care. deb:very sy~~m,s. 
(iv) U~x healtb-care systems. ·•::/~• >'·:: .>;. '·•:, ·. • .· ·: · .. 
(v) Organization within the drug-use dollliUn: who does · 
what and why. 
(vi) Epidemiology of drug use and misuse. 
(vii) Politics of health. 
(viii) Cui~: its role in shaping the system of care for a 
pOpiiliition: ·· 
(ix) Effecting change in organizations. 
(x) Co.titibn: positive and negative features. 
(xi) EConOrDic obstacles to and advantages of holistic phar-
macy. 
In behavioral pharmacy, empirical findings and theories from the 
behavioral and social sciences are taught and their applications to 
pharmacy are addressed. Some of the empirical fmdings that are 
taught can be characterized as scientific, while others are best de-
scribed as pre-scientific in that they are purely descriptive. Similarly, 
some of these theories qualify as scientific, while others do not. 
Examples of some more widely ceiebrated descliptive findings in 
behavioral pharmacy are: beneficial effects occur with about one out 
of every three placebo administrations, noncompliance ra~s 1111\. about 
35 percent on the average, and certain ethnic groups are notably mare 
stoic than Others. Examples of scientific data include findings that 
compliance is greater where the J!erceived efficacy of the drug is 
greater, ,the cost is low, and the illness is severe~ ~~ l~tter examples 
ar~ scientific and the previous examples are desertpbve, because the 
latter findings~ unlike the fonner, derive from and either corroborate 
or discc)nfimi scientific theory. •• ·. ' · · 
PopUlar nonscitntific theories include the sick role model of ·Par-
sons(3), the lay referral system of Freidson(4); the illness stage model 
of Suchman(S), Herzberg:s ,twC)-faptor, tlt~ry of employee. satisfac-
tion(6), ~ Maslc:nv.:.s hierarchial. th~ry.pf rn()tiV~()n(7). By calling 
these theories nonscientific, it is not intended to. discredit them but 
rather it is wished mereJy to draw attenti<>-::: ~ the fact that they are 
largely nonveridical; that is,,they are opt amenable eitlt~ to corrobora-
tion or to ~iion by empiric&l 'tesi; because they tend not to 
generitte_tes~fehyJJotbe8eS. · · /,, :;. · · · " ·. ·. · 
The h~~tific 56cliii' tllbories wbich are tallgJtt; like the de8crip~ 
tive data .tluii an, ~tC!d; have illeit userubie:ss Within a Iimiteci .oontext. 
The nonsCieiltifil the<Jries "iUtd ¥8Qiptive data serve by plugging in tiie·~~l~wll~ OJ!~;rt&aSMJriiii\iv but fiarudy does not, and as .such 
provide reasonable heuriStic guidelines or asSUmptive bases for action 
in the absence of scientific uDderstanding. Professors of behavioral 
sdeiiCti'how~~~·sbOOid take eare to recognize that these nonscien-
tific theories offen' are: li~ more thamlluisins; Since they cannot be 
proven as either .,..CorreCt .. or ~~iDCorrect/1 'these theories are of lim-
ited value~·theit'eontribution tO kllowltclge is·much less than it seems. 
Similarly;·~ptiire.datatellone how·many; whiit proportion, how 
m'udl;,aDCI iel&tiv~ to what, bUt since :tbey:'do not say why or how, 
they fai! to enlighten one•s ·UnCJerstanding:very much. The goal of 
~'iltd1~omt~sctentist5 shotild'be tO ~xpalid ~cieritific under-
stadcfiDg to'iePlD:theseheuristieswllenever and wherever possible. 
BEHAVIORAL PHARMACY RESEARCH 
The fli'St and 111ost telling ar~ment for ~ayio~ .P.~~~crresearch 
by teacher8 of the field is the need to· generate behavioral kriowledge 
and techniques es~ially for ph8rJDa((Y, The ¥JUis, C_91lllllission 
created the manc:lllte to develop behavioral and soeiai scienCe clirric1lla 
in colleges of pharmacy, but stopped short of defming what is to be 
taught from the behavioral scien~. II.. wise decisi9n, Jt is easy to 
recci~. the 111or,e glaring beha"viora,l needs . of pf:t,annacy, . but far 
more difficult to find existing scientific behavicmtl ~owl¢ge 19. s9~ve 
these probleJI!S. The llfational Institure,, of CIPJd )Jehavior llJld ~~ 
Development has .dec~ded. for exampl", to spen.d tl.l:~Jmore ,tp~ ,svt 
million doUars ~ocated to th~m by .aEW" for resean,:h 011 smoking 
8nd health in adolescents on basic.l'esear:ch ill. ~e ~ial ancl p~ycho­
logi~. faCtoJ;S ;Whi(!h·. encourage and. ~ter1 ~qt~s~nt ~~oking. ~­
thollg!t HE\\' S,ecretary Califano u.rged . th~t ,,dem9ns~ti9n,. an~­
smoking program~ be supported in.s~~opl.~ .•. !t. ~as,d~c:j(~~ .. that ~C)t 
enough is known yet about the t;elationships ~~ee11 psychosOCial 
variables and tobacco use to implement sophisti~ technology in 
the .schools, In contrast. to thjs more cautious appo@Ch, the tdf. Yule 
campaign .was inaugura,tecl with conside~l~,ent1tusiasm to d~rer the 
accidental .consumption of toxic chellli~s by young c~dren,. ~e 
need for such a gunpaign is real. However~ little or nothing is lcnown 
about how 'die particUlars of this cimlpliign inight motivate children in 
complex social sitUations; whether, for example, theMr. YUle stickers 
might arouse 8reater cUriosity than avoiaance where they are not 
acoorn anied b . arental reinforcement. . . ' .·. . 
In· J:e ca8e . af~ school .• smoldrig prevention prograD1s' and the 
Mr. Yuk C8fupaign; the temptation is to claiJn more than is ~o\Vii. In 
short, there is not a behavioral science knowled~e sufficiently f~used 
to the nCeds of the field to SUpPort' a SOphisticated bellavioJ'al phar-
macy technology tOday.· A knowledge base for beliaviotal' phaiiitacy 
must be developed, both at the basic and th~ applied levels. , 
·The knowledge base that is developed through behavioral pharmacy 
research should meet several criteria: it should relate.to drugs and the 
drug professions, to the. consumerll llfdrugs. and to the wellness 
behaviors that the pharmacist can teasonably ~xpect to affect (e.g;, 
smoking and eating pattems). WeUness behavior.includes concern 
with certain categories not (()mmoruy thought of as drug behaviors. 
,, 
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Fig. 1. The behavioral pharmacy cube. 
TOPICS (X) 
However, as the National Institute of Drug Abuse has recently ex-
tended its concern to include all classes of obsessive colisumatory 
behavior, including smoking and overeating, so too should pharmacy 
en~r this area of national concern with primary prevention. Behav-
ioral pharmacy should draw from and build upon the' knowledge and 
methodologies of the behavioral sciences. It should be scientific. In 
light of these criteria, behavioral pharmacy research can be defined in 
terrns of the. topics it addresses, the disciplines it encompasses, and 
the:. methQds by which it generates knowledge. This scheme is de-
picted gf<lphically in Figure 1. · 
Some examples of behavioral pharmacy research from the Social 
and Adrninisttative Pharmacy program at Minnesota are cited to dem-
onstrate discrete topic . by discipline by method interSections in the 
research cube. Research by Maiman and her colleagues on the health 
belief model as a predictor of patient compliance might fall into a 
compli~ce/sociology/quasi-experimental cell(17). Zander's particip-
ant observation research on the socialization of pharmacy stUdents 
m~ght be described by a pharmacist professional behavior/ 
anthrOpOlogy/observational~method intersection.• The research by 
Beardsley etal. on the effects of education and privacy on compliance 
falls into the compliance/psychology/experimental cell. Curtiss'(19) 
and Hiunmel's(20) work on the effects of role expectations on prac-
titioner . weQ~being belongs in the professional behavior/pharmacy/ 
quasi-experimental and professional behavior/psychology/quasi-
experimental cells. Boatman's research on the effects of a phar-
macokinetics program on patient outcomes in a bum treatment center 
belongs in the drug effects/pharmacy/quasi-experimental cell(21). 
Obviously, the combinations are numerous, but some cells are empty 
and will probably remain so .. For example, experimental anthrOpolog-
ical research in anything would be a self-contradiction. 
To better appreciate the scope of this 'task, it is helpful to consider 
in finer resolution the topics of behavioral pharmacy research. What 
research variables are likely to be pursued productively? Figure 2 
presents a matrix suggesting one way of constructing the, family of 
research variables relevant to behavioral pharmacy. Variables may be 
classified first by the level at which they are ,lplalyzed. For example, 
----------~.--- 1 1 Zander, D., "The Student Phannacist's Reality: A Phenomen~ogical Ap-
proach to Evaluation,'' paper presented to the annual meeting of the Amer-
ican Anthropological Association, Houston TX, Novembet/December 
1977. 
'' ', I~ 
locus of control, intelligence, and body weight are int{ivi4aal dijfer.l 
ence variables. Socio-economic status, farnily size,, group member-
ships, and cultural norms are social and cultural variables. Thinl7 
party payment systems, organizational hierarchy, a.nd legislative con-
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trol are systems variables. CatecJ:ao)amine levels, senun li.pi~. and 
cell receptor charaCteristics are {1itJ/o~~~~~~~:,~ ~~· ~ 
dosage and form ate flnlg Variables~ )i . < •:, ·~ : :: ? : . ··: ·. 
seru:vioral pbanwlcy ~ aisi,',i$ ~ceined wif!t another class 
of variables which might be ~bc!4. 8Ja prc:JCeSS vanables. Among 
the process variables are indi~ of~(~.~ with the 
overall health. and_ sense ,of well Oeing .of ~g consiJIDCrs. 
Etiology, pathogenesis dnd preV~bn ~/~er sd of process 
variables which concern bebavi(Jllli,Phan:nacy ~hers. For exam-
ple, at the University of Minnesota,·~ relationships be!Ween job 
stress, drug use, and Cllllfiovascular di~.-are being studied. ~er 
process variables iilclw:le the insttu~~~ e?t~tancy, and ~OCial 
variables which affeci .a per59n's perc~ptipn ofhisffler own illness, 
and the variables which affect the. pJtysici~Pt'~ diagnosis of disease 
(Hurd, for example, is. expio9ng a ~si~I~jl_efe~si~e billS of pe(}ple 
with chrome limitations to petcei"e th~lil.SClves. as better off than. they 
are). TreatTne1J! varjables. (cho,i~s of~~~~~~ treabllent eff~ve­
ness, adherence, etc~). are 0ne _other ci,~~· of ,proces~ vanables 
(Huang's recent ~h on t1te .~ff~ of e~~ identity on OTC drug 
use is an ex~le)(22). · . · .•.. '· · 
Other proCess variables include reh(Jbilitation from debilitating dis-
orders such as strokes, heart attacks, burns and other accidents; drug 
abuse, its causes and effects (Stergachis, for example, has designed a 
program to evaluate the effectiveness of various alcoholism treatment 
programs on patient outcomes2);professional behavior and outco,nes, 
such as indicators of quality of professional perfonnance and profes-
sional vitality and the rate of pharmacist attrition (research by Kabat, 
et al. is an example)(23) .. 
Other examples of behavioral pharmacy research at the University 
of Minnesota and their location in the grid depicted in Figure 2 are 
Smith's a:ttemptto putFreidsoil's lay referral system to a scien~c test 
(illness pereeptionftreatmerit bysocial variables interaction)(24) and 
LaiD.bert's research on dlug knowledge and OTC use (individual dif-
ference by treatment intersection)(25). Other examples are Werth-
eimer and Maiman's study on the effects of pharmaci~ts' attitudes on 
contraceptive advi~;e given to patients (professio1;1al behavior/ 
treatment by individual difference/enyiro~ent interactions)3 and 
Manasse's pioneering reseilrch on socialization in phannacy school 
(individual differencetculture/environmc:mt by professional behavior 
intersection)(26). · · · 
Psychometric insttument developmein and methodological innova-
tions are ilot represented in the matriX.' Some examples include Cyrs' 
work on assessment centers, 4 Grussing's behaviorally-anchored rating 
scales(27), Johnson, et al. 's development of the General Person 
Orientation Profile(28) and Bush's applications of path analysis tech-
niques.5 
RE.SEARCH METHODS FOR BEHAVIORAL 
PHARMACY . 
:1 
The development of behavioral science knowledge relevant to phar-
·macy calls for the use and elaboration of a large number of scientific 
research methods. Depending on the practical and ethical possibilities 
and constraints, the apPropriate method ~t any given moment may be 
a tightly controlled laboratruy experiment, a less well-controlled but 
rigorously designed quasi-experimental intervention, or systematic 
observations of naturally occurring social and health phenomena. The 
thoughtful and rigorous behavioral pharmacy researcher need not be 
emban:assed about less well-controlled methodologies if he/she uses 
them appropriately. Scientifically conceived and executed surveys, 
for example, are just as acceptable scientific methods as are systema-
tic astronomical observations. Whereas the well-conceived and rigor-
,ously executed experimental intervention is always the best route to 
causa:! understanding, there is nothing sacred about the experimental 
!Beth~. A soundly .~e:'soned and tig~tly constructed secondary 
lma:lySJs of already CX1Sting health data may contribute appreciably to 
scientific uO(Ierstulding. , ... . :, 
.Jl~~ ~tptiti9P,I~ '?fg~.~havi~~' pharmacy research is that it 
be ~C!'tific ~ ~C?ft~~~ H~Jae expenmental or that the data be non-
subjective, but that the.tesearch «Jerive from and be conceived so that 
it can be reasonably ~ to contribute to theoretical develop-
pie, ~hl,Ie tes9ng the hvr10thesis 
patie!lt educatic:m programs . . . .. , .· .coJillpl~a~tce, .o111e 
no well-articulated theoretical reason, s~ ~!1¢ili~Q~~.~t· 
tainment aecounts for a significant pioPQrtiOJ1 
pliance. Tiie advantage of "throWing in" the edttcational altta.i•Dtn~rit 
variable into a theoreticallyderived'expeJimeiltal 
going after it in a haphazardmultiviUiat~ way) is that one ~~~~·v ... _.•-
by the theory (and the research method appropriate to · 
to Iook·for interactions between education and the e1{fteri_Jrnetttal 
abies - interactions that might otheiJVise obscUre . be-
tween education and ·compliance iii'. a correlational .. or ,regreSsion 
analy~.i~.· . . , .. ·· . . ····. : . . , : 
It iS time nqw for behavi()ral phannacy formally to ~gruze _itself 
as an a~emic and a research discipline and, in so doing; to· tum 
away from its prescientific phase to enter with full conu¢~ent intO 
the scientific phase of its development. Tbi!! will be done by em-
phasizing hypothesis generation and testing (as oppoSed to desc.riptive 
research in what we do and teach) and by establishing for ourselves a 
common identity, characterized by widely accepted !kfmitiorui and 
visible forums for the exchange of information about ,the devel-
opments in this most important field. · · · 
Am. J. Pharm. Educ., 43, 257-261(1979); received l/9/79, accepted 6/19/ 
79. 
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A more appropriate title for this paper would be ''Pharmaceutical 
Psychology - Is There One?" Applications of psychological princi-
ples to pharmacy issues have been described, discussed and analyzed 
in the pharmacy literature but those issues which might comprise the 
discipline of pharmaceutical psychology have .been scattered through-
out the various pharmacy journals. This body of knowledge is incom-
plete, disconnected and unstructured. By completing, connecting and 
structuring this infonnation, the parameters, functions and idiosyn-
c~cies of this new aspect of pharmacy might become apparent. Or 
they might not. It is possible that pharmaceutical psychology as a 
discipline is an illusion - a relabeling of some issues and techniques 
that exist legitimately on their own, or which might be subsumed 
under health services research. 
·The purpose of this paper is to define those areas that could com-
prise pharmaceutical psychology so that an objective analysis and 
evaluation of the validity of this aspect of behavioral pharmacy can 
begin. This paper will include: (i) a review of the literature on the 
application and analysis of psychological principles to issues in phar-
macy; (ii) an outline of additional areas in pharmacy in which psy-
chologists could become involved; (iii) a description of a project 
involvmg the application of prose learning to the design of patient 
package inserts; and (iv) an analysis of the concept of p~armaceutical 
psychology. 
LITERATURE REVIEW 
The review of the literature included articles listed in International 
Pharmaceutical Abstracts, from January 1974 to February 1978, 
under the headings of: (i) Sociology, Economics and Ethics, (ii) 
Pharmacy Practice and (iii) Information Processing. 
Articles under the heading of Pharmacy Education were not 
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